The benefit of STent placement and blood pressure and lipid-lowering for the prevetion of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: Rationale and study design

Journal of Nephrology

Volumn 16, Issue 6, 2003, Pages 807-812

  Bax, Liesbeth ^a   Mali, W P Th M ^a   Buskens, Erik ^a   Koomans, Hein A ^a   Beutler, Jaap J ^a,h   Braam, B ^a   Beek, F J A ^a   Koomans, H A ^a   Rabelink, T J ^a   Postma, C T ^b   Huysmans, F T M ^b   Deinum, J ^b   Thien, Th ^b   Schultze Kool, L J ^b   Woittiez, A J J ^c   Kouwenberg, J J ^c   van den Meiracker, A H ^d   Pattynama, P M T ^d   van den Ven, P J G ^e   Vroegindeweij, D ^e   Doorenbos, C J ^f   Aarts, J C N M ^f   Kroon, A A ^g   de Leeuw, P W ^g   de Haan, M W ^g   van Engelshoven, J M A ^g   Rutten, M J C M ^h   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TWENTEBORG HOSPITAL   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e St Clara Hospital   (Netherlands)

^f DEVENTER HOSPITAL   (Netherlands)

^g MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^h JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

Atherosclerosis; Atorvastatin; Glomerulosclerosis; Hypertension; Intervention; Intihypertensives; Randomized trial; Renal artery stenosis; Renal failure; Renovascular disease; Statin; Stent; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIAZIDE DIURETIC AGENT; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MAJOR CLINICAL STUDY; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK MANAGEMENT; STENT; TREATMENT OUTCOME; ARTERIOSCLEROSIS; KIDNEY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RENAL ARTERY;

ANGIOPLASTY, BALLOON; ANTIHYPERTENSIVE AGENTS; ARTERIOSCLEROSIS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY; PYRROLES; RENAL ARTERY; RENAL ARTERY OBSTRUCTION; RESEARCH DESIGN; STENTS;

EID: 1642568707     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998; 31: 971-7.
2. Harden PN, MacLeod MJ, Rodger RS. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-6.
3. Appel RG, Bleyer AJ, Reavis S, Hansen KJ. Renovascular disease in older patients beginning renal replacement therapy. Kidney Int 1995; 48: 171-6.
4. Meyrier A, Hill GS, Simon P. Ischemic renal diseases: new insights into old entities. Kidney Int 1998; 54: 2-13.
5. Rees CR, Palmaz JC, Becker GJ. Palmaz stent in atherosclerotic stenoses involving the ostia of the renal arteries: preliminary report of a multicenter study. Radiology 1991; 181: 507-14.
6. Leertouwer TC, Gussenhoven EJ, Bosch JL. Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216: 78-85.
7. Beutler JJ, Ampting JM, van de Ven PJ. Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol 2001; 12: 1475-81.
8. Bush RL, Martin LG, Lin PH. Endovascular revascularization of renal artery stenosis in the solitary functioning kidney. Ann Vasc Surg 2001; 15: 60-6.
9. Rundback JH, Gray RJ, Rozenblit G. Renal artery stent placement for the management of ischemic nephropathy.J Vasc Intervent Radiol 1998; 9: 413-20.
10. Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-7.
11. Wright JR, Shurrab AE, Cheung C. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis 2002; 39: 1153-61.
12. Beek FJ, Kaatee R, Beutler JJ, van de Ven PJ, Mali WP. Complications during renal artery stent placement for atherosclerotic ostial stenosis. Cardiovasc Intervent Radiol 1997; 20: 184-90.
13. Dean RH, Kieffer RW, Smith BM. Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch Surg 1981; 116: 1408-15.
14. Schreiber MJ, Pohl MA, Novick AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am 1984; 11: 383-92.
15. Martinez-Maldonado M. Role of hypertension in the progression of chronic renal disease. Nephrol Dial Transplant 2001; 16 (suppl 1): S63-6.
16. Jackson B, Franze L, Sumithran E, Johnston CI. Pharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat. J Lab Clin Med 1990; 115: 21-7.
17. Chade AR, Rodriguez-Porcel M, Grande JP. Distinct renal injury in early atherosclerosis and renovascular disease. Circulation 2002; 106: 1165-71.
18. Diamond JR, Karnovsky MJ. Focal and segmental glomerulosclerosis: analogies to atherosclerosis. Kidney Int 1988; 33: 917-24.
19. Suresh M, Laboi P, Mamtora H, Kalra PA. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol Dial Transplant 2000; 15: 631-6.
20. Wright JR, Duggal A, Thomas R. Clinicopathological correlation in biopsy-proven atherosclerotic nephropathy: implications for renal functional outcome in atherosclerotic renovascular disease. Nephrol Dial Transplant 2001; 16: 765-70.
21. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987; 31: 1153-59.
22. Manttari M, Tiula E, Alikoski T, Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 1995; 26: 670-5.
23. Oda H, Keane WF. Recent advances in statins and the kidney. Kidney Int 1999; 71 (suppl XX): S2-5.
24. Fried LF, Orchard TJ, Kasiske BL. Effect of lipid reduction on the progression of renal disease: a meta-analysis. Kidney Int 2001; 59: 260-9.
25. Basta LL, Williams C, Kioschos JM, Spector AA. Regression of atherosclerotic stenosing lesions of the renal arteries and spontaneous cure of systemic hypertension through control of hyperlipidemia. Am J Med 1976; 61: 420-3.
26. Orth SR. Smoking and the kidney. J Am Soc Nephrol 2002; 13: 1663-72.